The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes

Journal of Autoimmunity

Volumn 34, Issue 4, 2010, Pages 371-379

  Sellner, Johann ^a   Hemmer, Bernhard ^a   Mühlau, Mark ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aquaporin 4; Longitudinally extensive myelitis; Neuromyelitis optica; Optic neuritis; Parainfectious

Indexed keywords

ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; AQUAPORIN 4; CORTICOSTEROID; ERYTHROMYCIN; IMMUNOGLOBULIN; MITOXANTRONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENICILLIN G; PROTEIN ANTIBODY; STEROID; TUBERCULOSTATIC AGENT;

ACUTE DISEASE; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BACTERIAL PNEUMONIA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISABILITY; DISEASE EXACERBATION; DRUG MEGADOSE; FEVER; HUMAN; IMMUNOBIOLOGY; IMMUNOSTIMULATION; MYCOBACTERIOSIS; MYELOOPTIC NEUROPATHY; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; PLASMAPHERESIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SEROLOGY; SPINAL CORD INFECTION; SYMPTOM; SYSTEMIC DISEASE; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ADULT; CENTRAL NERVOUS SYSTEM; CHILD; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; INFECTION; INFLAMMATION; MALE; MYCOBACTERIUM; NEUROMYELITIS OPTICA;

EID: 77952236654     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.09.013     Document Type: Review

References (91)

1. Wingerchuk D.M., Lennon V.A., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. The spectrum of neuromyelitis optica. Lancet Neurol 2007, 6:805-815.
2. Wegner C. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system. Int MS J 2005, 12:13-19. 12.
3. Lennon V.A., Wingerchuk D.M., Kryzer T.J., Pittock S.J., Lucchinetti C.F., Fujihara K., et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004, 364:2106-2112.
4. Matsuoka T., Matsushita T., Kawano Y., Osoegawa M., Ochi H., Ishizu T., et al. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese. Brain 2007, 130:1206-1223.
5. Pittock S.J., Weinshenker B.G., Lucchinetti C.F., Wingerchuk D.M., Corboy J.R., Lennon V.A. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006, 63:964-968.
6. McKeon A., Lennon V.A., Lotze T., Tenenbaum S., Ness J.M., Rensel M., et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008, 71:93-100.
7. Wingerchuk D.M., Hogancamp W.F., O'Brien P.C., Weinshenker B.G. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999, 53:1107-1114.
8. Papais-Alvarenga R.M., Miranda-Santos C.M., Puccioni-Sohler M., de Almeida A.M., Oliveira S., Basilio De Oliveira C.A., et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002, 73:429-435.
9. de Seze J., Stojkovic T., Ferriby D., Gauvrit J.Y., Montagne C., Mounier-Vehier F., et al. Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002, 197:57-61.
10. Wingerchuk D.M., Weinshenker B.G. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003, 60:848-853.
11. Jacob A., Matiello M., Wingerchuk D.M., Lucchinetti C.F., Pittock S.J., Weinshenker B.G. Neuromyelitis optica: changing concepts. J Neuroimmunol 2007, 187:126-138.
12. Scolding N. Devic's disease and autoantibodies. Lancet Neurol 2005, 4:136-137.
13. Menge T., Hemmer B., Nessler S., Wiendl H., Neuhaus O., Hartung H.P., et al. Acute disseminated encephalomyelitis: an update. Arch Neurol 2005, 62:1673-1680.
14. Höllinger P., Sturzenegger M., Mathis J., Schroth G., Hess C.W. Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF EEG MRI findings. J Neurol 2002, 249:320-329.
15. Schwarz S., Mohr A., Knauth M., Wildemann B., Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001, 56:1313-1318.
16. Wingerchuk D.M., Lennon V.A., Pittock S.J., Lucchinetti C.F., Weinshenker B.G. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006, 66:1485-1489.
17. Silber M.H., Willcox P.A., Bowen R.M., Unger A. Neuromyelitis optica (Devic's syndrome) and pulmonary tuberculosis. Neurology 1990, 40:934-938.
18. Nielsen S., Nagelhus E.A., Amiry-Moghaddam M., Bourque C., Agre P., Ottersen O.P. Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain. J Neurosci 1997, 17:171-180.
19. Roemer S.F., Parisi J.E., Lennon V.A., Benarroch E.E., Lassmann H., Bruck W., et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007, 130:1194-1205.
20. Hamann S., Zeuthen T., La Cour M., Nagelhus E.A., Ottersen O.P., Agre P., et al. Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye. Am J Physiol 1998, 274:C1332-C1345.
21. Gomes D., Agasse A., Thiebaud P., Delrot S., Geros H., Chaumont F. Aquaporins are multifunctional water and solute transporters highly divergent in living organisms. Biochim Biophys Acta 2009, 1788:1213-1228.
22. Ishibashi K., Hara S., Kondo S. Aquaporin water channels in mammals. Clin Exp Nephrol 2009, 13:107-117.
23. Hinson S.R., Pittock S.J., Lucchinetti C.F., Roemer S.F., Fryer J.P., Kryzer T.J., et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69:2221-2231.
24. Jarius S., Aboul-Enein F., Waters P., Künz B., Hauser A., Berger T., et al. Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 2008, 131:3072-3080.
25. Takahashi T., Fujihara K., Nakashima I., Misu T., Miyazawa I., Nakamura M., et al. Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. Brain 2007, 130:1235-1243.
26. Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol, in press.
27. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol, in press.
28. Kim J.H., Kim J.H., Park J.A., Lee S.W., Kim W.J., Yu Y.S., et al. Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 2006, 39:339-345.
29. Vincent T., Saikali P., Cayrol R., Roth A.D., Bar-Or A., Prat A., et al. Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment. J Immunol 2008, 181:5730-5737.
30. Bach J.F. Infections and autoimmune diseases. J Autoimmun 2005, 25(Suppl.):74-80.
31. Avrameas S., Ternynck T., Tsonis I.A., Lymberi P. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 2007, 29:213-218.
32. Invernizzi P, Gershwin ME. The genetics of human autoimmune disease. J Autoimmun, in press.
33. Anolik JH, Looney RJ, Lund FE, Randall TD, Sanz I. Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets. Immunol Res, in press.
34. van Zwam M., Huizinga R., Melief M.J., Wierenga-Wolf A.F., van Meurs M., Voerman J.S., et al. Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J Mol Med 2009, 87:273-286.
35. Graber D.J., Levy M., Kerr D., Wade W.F. Neuromyelitis optica pathogenesis and aquaporin 4. J. Neuroinflammation 2008, 5:22.
36. Christen U, Hintermann E, Holdener M, von Herrath MG.Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty? J Autoimmun, in press.
37. Montes C.L., Acosta-Rodriguez E.V., Merino M.C., Bermejo D.A., Gruppi A. Polyclonal B cell activation in infections: infectious agents' devilry or defense mechanism of the host?. J Leukoc Biol 2007, 82:1027-1032.
38. Mackay I.R., Leskovsek N.V., Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 2008, 30:5-11.
39. Carson M.J., Doose J.M., Melchior B., Schmid C.D., Ploix C.C. CNS immune privilege: hiding in plain sight. Immunol Rev 2006, 213:48-65.
40. Heerlein K., Jarius S., Jacobi C., Rohde S., Storch-Hagenlocher B., Wildemann B. Aquaporin-4 antibody positive longitudinally extensive transverse myelitis following varicella zoster infection. J Neurol Sci 2009, 276:184-186.
41. Weinshenker B.G., Wingerchuk D.M., Vukusic S., Linbo L., Pittock S.J., Lucchinetti C.F., et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006, 59:566-569.
42. Lalive P.H., Menge T., Barman I., Cree B.A., Genain C.P. Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays. Neurology 2006, 67:176-177.
43. Ryan K.R., Patel S.D., Stephens L.A., Anderton S.M. Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 2007, 29:262-271.
44. Sospedra M., Martin R. Molecular mimicry in multiple sclerosis. Autoimmunity 2006, 39:3-8.
45. Zephir H., Fajardy I., Outteryck O., Blanc F., Roger N., Fleury M., et al. Is neuromyelitis optica associated with human leukocyte antigen?. Mult Scler 2009, 15:571-579.
46. Gilden D.H. Multiple sclerosis exacerbations and infection. Lancet Neurol 2002, 1:145.
47. Rapp N.S., Gilroy J., Lerner A.M. Role of bacterial infection in exacerbation of multiple sclerosis. Am J Phys Med Rehabil 1995, 74:415-418.
48. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci 2008, 28:9451-9462.
49. Bizzoco E, Lolli F, Repice AM, Hakiki B, Falcini M, Barilaro A, et al. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution. J Neurol, in press.
50. Sellner J., Lüthi N., Schüpbach W.M., Gebhardt A., Findling O., Schroth G., et al. Diagnostic workup of patients with acute transverse myelitis: spectrum of clinical presentation, neuroimaging and laboratory findings. Spinal Cord 2009, 47:312-317.
51. Lotze T.E., Northrop J.L., Hutton G.J., Ross B., Schiffman J.S., Hunter J.V. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008, 122:e1039-e1047.
52. Gupte G., Stonehouse M., Wassmer E., Coad N.A., Whitehouse W.P. Acute disseminated encephalomyelitis: a review of 18 cases in childhood. J Paediatr Child Health 2003, 39:336-342.
53. Tenembaum S., Chamoles N., Fejerman N. Acute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients. Neurology 2002, 59:1224-1231.
54. Marchioni E., Ravaglia S., Piccolo G., Furione M., Zardini E., Franciotta D., et al. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 2005, 65:1057-1065.
55. Buljevac D., Flach H.Z., Hop W.C., Hijdra D., Laman J.D., Savelkoul H.F., et al. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002, 125:952-960.
56. Jarius S., Franciotta D., Bergamaschi R., Rauer S., Wandinger K.P., Petereit H.F., et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J Neurol Neurosurg Psychiatry 2008, 79:1134-1136.
57. Noorbakhsh F., Johnson R.T., Emery D., Power C. Acute disseminated encephalomyelitis: clinical and pathogenesis features. Neurol Clin 2008, 26:759-780. [ix].
58. van Assen S., Bosma F., Staals L.M., Kullberg B.J., Melchers W.J., Lammens M., et al. Acute disseminated encephalomyelitis associated with Borrelia burgdorferi. J Neurol 2004, 251:626-629.
59. Spieker S., Petersen D., Rolfs A., Fehrenbach F., Kuntz R., Seuffer R.H., et al. Acute disseminated encephalomyelitis following Pontiac fever. Eur Neurol 1998, 40:169-172.
60. Alonso-Valle H., Munoz R., Hernandez J.L., Matorras P. Acute disseminated encephalomyelitis following Leptospira infection. Eur Neurol 2001, 46:104-105.
61. Papazisi L., Gorton T.S., Kutish G., Markham P.F., Browning G.F., Nguyen D.K., et al. The complete genome sequence of the avian pathogen Mycoplasma gallisepticum strain R(low). Microbiology 2003, 149:2307-2316.
62. Lana-Peixoto M, Cabral L, Muniz A. Optic neuromyelitis in Schistosomiasis mansoni. In: 27th Annu North Am Neuro-Opththalmology Soc Meet Calif United State; 2001: 56-56.
63. Lana-Peixoto M.A. Devic's neuromyelitis optica: a critical review. Arq Neuropsiquiatr 2008, 66:120-138.
64. Riedel K., Kempf V.A., Bechtold A., Klimmer M. Acute disseminated encephalomyelitis (ADEM) due to Mycoplasma pneumoniae infection in an adolescent. Infection 2001, 29:240-242.
65. Alehan F.K., Kahveci S., Uslu Y., Yildirim T., Yilmaz B. Acute disseminated encephalomyelitis associated with hepatitis A virus infection. Ann Trop Paediatr 2004, 24:141-144.
66. Au W.Y., Lie A.K., Cheung R.T., Cheng P.W., Ooi C.G., Yujenc K.Y., et al. Acute disseminated encephalomyelitis after para-influenza infection post bone marrow transplantation. Leuk Lymphoma 2002, 43:455-457.
67. Sacconi S., Salviati L., Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001, 58:1679-1681.
68. Lepur D., Peterkovic V., Kalabric-Lepur N. Neuromyelitis optica with CSF examination mimicking bacterial meningomyelitis. Neurol Sci 2009, 30:51-54.
69. O'Riordan J.I., Gallagher H.L., Thompson A.J., Howard R.S., Kingsley D.P., Thompson E.J., et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996, 60:382-387.
70. O'Riordan J.I., Gomez-Anson B., Moseley I.F., Miller D.H. Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease. J Neurol Sci 1999, 167:132-136.
71. de Seze J., Debouverie M., Zephir H., Lebrun C., Blanc F., Bourg V., et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol 2007, 64:1426-1432.
72. Wingerchuk D.M. Diagnosis and treatment of neuromyelitis optica. Neurologist 2007, 13:2-11.
73. Magana S.M., Matiello M., Pittock S.J., McKeon A., Lennon V.A., Rabinstein A.A., et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009, 72:712-717.
74. Hynson J.L., Kornberg A.J., Coleman L.T., Shield L., Harvey A.S., Kean M.J. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 2001, 56:1308-1312.
75. Sellner J., Lüthi N., Bühler R., Gebhardt A., Findling O., Greeve I., et al. Acute partial transverse myelitis: risk factors for conversion to multiple sclerosis. Eur J Neurol 2008, 15:398-405.
76. Blank M., Shoenfeld Y. B cell targeted therapy in autoimmunity. J Autoimmun 2007, 28:62-68.
77. Tran C., Du Pasquier R.A., Cavassini M., Guex-Crosier Y., Meuli R., Ciuffreda D., et al. Neuromyelitis optica following CMV primo-infection. J Intern Med 2007, 261:500-503.
78. Miranda de Sousa A., Puccioni-Sohler M., Dias Borges A., Fernandes Adorno L., Papais Alvarenga M., Papais Alvarenga R.M. Post-dengue neuromyelitis optica: case report of a Japanese-descendent Brazilian child. J Infect Chemother 2006, 12:396-398.
79. Jouhadi Z., Ouazzani I., Abid A., El Moutawakil B., Rafai M.A., Slassi I. Neuromyelite optique de Devic et hepatite virale A. A propos d'une observation pediatrique. Rev Neurol (Paris) 2004, 160:1198-1202.
80. Blanche P., Diaz E., Gombert B., Sicard D., Rivoal O., Brezin A. Devic's neuromyelitis optica and HIV-1 infection. J Neurol Neurosurg Psychiatry 2000, 68:795-796.
81. Merle H., Smadja D., Cordoba A. Neuromyelite optique et necrose retinienne aigue bilaterale d'origine zosterienne chez une patiente atteinte du SIDA. J Fr Ophtalmol 1998, 21:381-386.
82. Ahasan H.A., Rafiqueuddin A.K., Chowdhury M.A., Azhar M.A., Kabir F. Neuromyelitis optica (Devic's disease) following chicken pox. Trop Doct 1994, 24:75-76.
83. al-Deeb S.M., Yaqub B.A., Khoja W.O. Devic's neuromyelitis optica and varicella. J Neurol 1993, 240:450-451.
84. Bruguier A., Ponsot G., Khouri-Dagher L., de Leersnyder H. Neuromyelite optique ou maladie de Devic, compliquant une varicelle. Arch Fr Pediatr 1981, 38:763-764.
85. Chusid M.J., Williamson S.J., Murphy J.V., Ramey L.S. Neuromyelitis optica (Devic disease) following varicella infection. J Pediatr 1979, 95:737-738.
86. Doutlik S., Sblova O., Kryl R., Novak M. Neuromyelitis optica jako parainfekcni komplikace planych nestovic. Cesk Neurol Neurochir 1975, 38:238-242.
87. Williamson P.M. Neuromyelitis optica following infectious mononucleosis. Proc Aust Assoc Neurol 1975, 12:153-155.
88. Gebhardt A., Bühler R., Wiest R., Tewald F., Sellner J., Humpert S., et al. Mycoplasma pneumonia as a cause of neuromyelitis optica?. J Neurol 2008, 255:1268-1269.
89. Wilcox R.A., Burrow J., Slee M., Craig J., Thyagarajan D. Neuromyelitis optica (Devic's disease) in a patient with syphilis. Mult Scler 2008, 14:268-271.
90. El Otmani H., Rafai M.A., Moutaouakil F., El Moutawakkil B., Gam I., El Meziane A., et al. Neuromyelite optique de Devic associee a une tuberculose pulmonaire. Rev Mal Respir 2005, 22:143-146.
91. Barbizet J., Degos J.D., Meyrignac C. Neuromyelite optique aigue associee a une tuberculose pulmonaire aigue. Rev Neurol (Paris) 1980, 136:303-309.